Hypoxia-inducible factor 1 alpha in oral squamous cell carcinoma and its relation to prognosis

Oral Oncology

Volumn 45, Issue 3, 2009, Pages 241-246

  Uehara, Masataka ^a   Sano, Kazuo ^b   Ikeda, Hisazumi ^a   Nonaka, Mihoko ^a   Asahina, Izumi ^a  

^a NAGASAKI UNIVERSITY GRADUATE SCHOOL OF BIOMEDICAL SCIENCES   (Japan)

^b University of Fukui   (Japan)

Author keywords

Hypoxia inducible factor 1 alpha; Oral squamous cell carcinoma; Prognosis

Indexed keywords

CYCLINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1;

ARTICLE; CANCER PATIENT; CANCER STAGING; CELL ACTIVITY; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE MARKER; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; ORAL BIOPSY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; SQUAMOUS CELL CARCINOMA; TUMOR CELL; BIOSYNTHESIS; DISEASE COURSE; JAPAN; METABOLISM; MOUTH TUMOR; PATHOLOGY; PRECANCER;

CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; JAPAN; LYMPHATIC METASTASIS; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; PROGNOSIS; PROLIFERATING CELL NUCLEAR ANTIGEN;

EID: 60249101964     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.05.007     Document Type: Article

References (39)

1. Kawanishi S., and Hiraku Y. Oxidative and nitrative DNA damage as biomarker for carcinogenesis with special reference to inflammation. Antioxid Redox Signal 8 5-6 (2006) 1047-1058
2. Munoz A.A., Haddad R.I., Woo S.B., and Bhattacharyya N. Behavior of oral squamous cell carcinoma in subjects with prior lichen planus. Otolaryngol Head Neck Surg 136 3 (2007) 401-404
3. Mignogna M.D., Fedele S., Lo Russo L., Mignogna C., de Rosa G., and Porter S.R. Field cancerization in oral lichen planus. Eur J Surg Oncol 33 3 (2007) 383-389
4. Winter S.C., Shah K.A., Campo L., Turley H., Leek R., Corbridge R.J., et al. Relation of erythropoietin and erythropoietin receptor expression to hypoxia and anemia in head and neck squamous cell carcinoma. Clin Cancer Res 11 21 (2005) 7614-7620
5. Shweiki D., Itin A., Soffer D., and Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359 6398 (1992) 843-845
6. Grimshaw M.J., Naylor S., and Balkwill F.R. Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells. Mol Cancer Ther 1 14 (2002) 1273-1281
7. Chen E.Y., Mazure N.M., Cooper J.A., and Giaccia A.J. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Cancer Res 61 6 (2001) 2429-2433
8. Ishibashi H., Shiratuchi T., Nakagawa K., Onimaru M., Sugiura T., Sueishi K., et al. Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release. Oral Oncol 37 1 (2001) 77-83
9. Saintigny P., Besse B., Callard P., Vergnaud A.C., Czernichow S., Colombat M., et al. Erythropoietin and erythropoietin receptor coexpression is associated with poor survival in stage I non-small cell lung cancer. Clin Cancer Res 13 16 (2007) 4825-4831
10. Uehara M., Sano K., Ikeda H., Sekine J., Irie A., Yokota T., et al. Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma. Oral Oncol 40 3 (2004) 321-325
11. Ishibashi Y., Hanyu N., Nakada K., Suzuki Y., Yamamoto T., Takahashi T., et al. Endothelin protein expression as a significant prognostic factor in oesophageal squamous cell carcinoma. Eur J Cancer 39 10 (2003) 1409-1415
12. Matsumoto S., Yamada Y., Narikiyo M., Ueno M., Tamaki H., Miki K., et al. Prognostic significance of platelet-derived growth factor-BB expression in human esophageal squamous cell carcinomas. Anticancer Res 27 4B (2007) 2409-2414
13. Barclay C., Li A.W., Geldenhuys L., Baguma-Nibasheka M., Porter G.A., Veugelers P.J., et al. Basic fibroblast growth factor (FGF-2) overexpression is a risk factor for esophageal cancer recurrence and reduced survival, which is ameliorated by coexpression of the FGF-2 antisense gene. Clin Cancer Res 11 21 (2005) 7683-7691
14. 2 tension. Proc Natl Acad Sci USA 92 12 (1995) 5510-5514
15. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12 2 (1998) 149-162
16. Minchenko A., and Caro J. Regulation of endothelin-1 gene expression in human microvascular endothelial cells by hypoxia and cobalt: role of hypoxia responsive element. Mol Cell Biochem 208 1-2 (2000) 53-62
17. Bachtiary B., Schindl M., Potter R., Dreier B., Knocke T.H., Hainfellner J.A., et al. Overexpression of hypoxia-inducible factor 1alpha indicates diminished response to radiotherapy and unfavorable prognosis in patients receiving radical radiotherapy for cervical cancer. Clin Cancer Res 9 6 (2003) 2234-2240
18. Schindl M., Schoppmann S.F., Samonigg H., Hausmaninger H., Kwasny W., Gnant M., et al. Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer. Clin Cancer Res 8 6 (2002) 1831-1837
19. Theodoropoulos V.E., Lazaris A., Sofras F., Gerzelis I., Tsoukala V., Ghikonti I., et al. Hypoxia-inducible factor 1 alpha expression correlates with angiogenesis and unfavorable prognosis in bladder cancer. Eur Urol 46 2 (2004) 200-208
20. Liu S.Y., Chang L.C., Pan L.F., Hung Y.J., Lee C.H., and Shieh Y.S. Clinicopathologic significance of tumor cell-lined vessel and microenvironment in oral squamous cell carcinoma. Oral Oncol 30 (2007) 30
21. Sano K., Takahashi H., Fujita S., Inokuchi T., Pe M.B., Okabe H., et al. Prognostic implication of silver-binding nucleolar organizer regions (AgNORs) in oral squamous cell carcinoma. J Oral Pathol Med 20 2 (1991) 53-56
22. Schildt E.B., Nylander K., Eriksson M., Hardell L., Magnusson A., and Roos G. Expression of p53, PCNA, Ki-67 and bcl-2 in relation to risk factors in oral cancer - a molecular epidemiological study. Int J Oncol 22 4 (2003) 861-868
23. Celis J.E., and Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci USA 82 10 (1985) 3262-3266
24. Wu L.C., D'Amelio F., Fox R.A., Polyakov I., and Daunton N.G. Light microscopic image analysis system to quantify immunoreactive terminal area apposed to nerve cells. J Neurosci Meth 74 1 (1997) 89-96
25. Leal S., Diniz C., Sa C., Goncalves J., Soares A.S., Rocha-Pereira C., et al. Semiautomated computer-assisted image analysis to quantify 3,3'-diaminobenzidine tetrahydrochloride-immunostained small tissues. Anal Biochem 357 1 (2006) 137-143
26. Matos L.L., Stabenow E., Tavares M.R., Ferraz A.R., Capelozzi V.L., and Pinhal M.A. Immunohistochemistry quantification by a digital computer-assisted method compared to semiquantitative analysis. Clinics 61 5 (2006) 417-424
27. Odell E.W., Jani P., Sherriff M., Ahluwalia S.M., Hibbert J., Levison D.A., et al. The prognostic value of individual histologic grading parameters in small lingual squamous cell carcinomas. The importance of the pattern of invasion. Cancer 74 3 (1994) 789-794
28. Sawair F.A., Irwin C.R., Gordon D.J., Leonard A.G., Stephenson M., and Napier S.S. Invasive front grading: reliability and usefulness in the management of oral squamous cell carcinoma. J Oral Pathol Med 32 1 (2003) 1-9
29. Frixen U.H., Behrens J., Sachs M., Eberle G., Voss B., Warda A., et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113 1 (1991) 173-185
30. Menezes M.B., Lehn C.N., and Goncalves A.J. Epidemiological and histopathological data and E-cadherin-like prognostic factors in early carcinomas of the tongue and floor of mouth. Oral Oncol 43 7 (2007) 656-661
31. Imai T., Horiuchi A., Wang C., Oka K., Ohira S., Nikaido T., et al. Hypoxia attenuates the expression of E-cadherin via up-regulation of SNAIL in ovarian carcinoma cells. Am J Pathol 163 4 (2003) 1437-1447
32. Aebersold D.M., Burri P., Beer K.T., Laissue J., Djonov V., Greiner R.H., et al. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer. Cancer Res 61 7 (2001) 2911-2916
33. Fillies T., Werkmeister R., van Diest P.J., Brandt B., Joos U., and Buerger H. HIF1-alpha overexpression indicates a good prognosis in early stage squamous cell carcinomas of the oral floor. BMC Cancer 5 (2005) 84
34. de Vicente J.C., Lequerica-Fernandez P., Santamaria J., and Fresno M.F. Expression of MMP-7 and MT1-MMP in oral squamous cell carcinoma as predictive indicator for tumor invasion and prognosis. J Oral Pathol Med 36 7 (2007) 415-424
35. Patel B.P., Shah S.V., Shukla S.N., Shah P.M., and Patel P.S. Clinical significance of MMP-2 and MMP-9 in patients with oral cancer. Head Neck 29 6 (2007) 564-572
36. Miyazaki Y., Hara A., Kato K., Oyama T., Yamada Y., Mori H., et al. The effect of hypoxic microenvironment on matrix metalloproteinase expression in xenografts of human oral squamous cell carcinoma. Int J Oncol 32 1 (2008) 145-151
37. Wijffels K.I., Marres H.A., Peters J.P., Rijken P.F., van der Kogel A.J., and Kaanders J.H. Tumour cell proliferation under hypoxic conditions in human head and neck squamous cell carcinomas. Oral Oncol 3 (2007) 3
38. Ljungkvist A.S., Bussink J., Rijken P.F., Kaanders J.H., van der Kogel A.J., and Denekamp J. Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas. Int J Radiat Oncol Biol Phys 54 1 (2002) 215-228
39. Hoogsteen I.J., Marres H.A., Wijffels K.I., Rijken P.F., Peters J.P., van den Hoogen F.J., et al. Colocalization of carbonic anhydrase 9 expression and cell proliferation in human head and neck squamous cell carcinoma. Clin Cancer Res 11 1 (2005) 97-106